{'output': [['Mallinckrodt Plc', 'ORG', 'Sell', 'Recothrom® and Preveleak®', 'PRODUCT'], ['Mallinckrodt Plc', 'ORG', 'Retain', 'Raplixa', 'PRODUCT'], ['Mallinckrodt Plc', 'ORG', 'Evaluating', 'Strategic Options', 'CONCEPT', 'For', 'Raplixa', 'PRODUCT'], ['Mallinckrodt Plc', 'ORG', 'Impact', 'Adjusted Earnings Per Share', 'ECON_INDICATOR', 'By', '$0.10 to $0.15', 'ECON_INDICATOR', 'In', '2018'], ['Mallinckrodt Plc', 'ORG', 'Discontinue', 'Marketing of Raplixa', 'PRODUCT', 'Upon Close', 'Baxter Transaction'], ['Mallinckrodt Plc', 'ORG', 'Use', 'Proceeds from Sale', 'CONCEPT', 'To Pay Down', 'Debt', 'CONCEPT'], ['Mallinckrodt Plc', 'ORG', 'Write-Off', 'Raplixa', 'PRODUCT', 'Reported', 'Q4 2017']]}